View Post

New therapy extends breast cancer survival rate, prevents reoccurrence

In Clinical Studies News by Barbara Jacoby

By: Northwestern University From: A new immunotherapy developed by researchers at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer. In a new study, mice treated with the therapy, which comprises two immunity-boosting drugs housed inside a nanoparticle, experienced complete tumor remission for …